InvesTrust’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.69M Sell
5,576
-208
-4% -$213K 2.57% 11
2026
Q1
$5.32M Sell
5,784
-129
-2% -$131K 2.24% 15
2025
Q4
$6.35M Sell
5,913
-601
-9% -$575K 2.46% 10
2025
Q3
$4.97M Sell
6,514
-14
-0.2% -$10.4K 1.82% 16
2025
Q2
$5.09M Sell
6,528
-4,313
-40% -$3.35M 1.96% 15
2025
Q1
$8.95M Sell
10,841
-540
-5% -$449K 2.45% 7
2024
Q4
$8.8M Buy
+11,381
New +$9.42M 2.45% 5

Other funds holding LLY

InvesTrust's LLY Position: Q2 2026 in Review

InvesTrust reduced its Eli Lilly (LLY) stake by 3.6% in Q2 2026, selling an estimated $213K and leaving 5,576 shares worth $6.69M. The position accounts for 2.57% of the portfolio, ranked #11.

InvesTrust first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. The position peaked at $8.95M in Q1 2025. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • InvesTrust held 5,576 shares of Eli Lilly worth $6.69M as of Q2 2026.
  • InvesTrust sold 208 Eli Lilly shares in Q2 2026, an estimated $213K.
  • Eli Lilly made up 2.57% of InvesTrust's portfolio in Q2 2026, its #11 holding.
  • InvesTrust first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • InvesTrust's Eli Lilly position peaked at $8.95M in Q1 2025.
  • 2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on InvesTrust's 13F filing for Q2 2026, filed 14 Jul 2026.